TD Asset Management’s Voyager Therapeutics VYGR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $237K | Hold |
76,330
| – | – | ﹤0.01% | 1174 |
|
|
2025
Q1 | $258K | Sell |
76,330
-38,600
| -34% | -$130K | ﹤0.01% | 1185 |
|
|
2024
Q4 | $652K | Hold |
114,930
| – | – | ﹤0.01% | 1157 |
|
|
2024
Q3 | $672K | Sell |
114,930
-46,998
| -29% | -$275K | ﹤0.01% | 1258 |
|
|
2024
Q2 | $1.28M | Hold |
161,928
| – | – | ﹤0.01% | 1116 |
|
|
2024
Q1 | $1.51M | Buy |
161,928
+28,426
| +21% | +$265K | ﹤0.01% | 1092 |
|
|
2023
Q4 | $1.13M | Hold |
133,502
| – | – | ﹤0.01% | 1158 |
|
|
2023
Q3 | $1.03M | Buy |
133,502
+66,751
| +100% | +$517K | ﹤0.01% | 1134 |
|
|
2023
Q2 | $764K | Buy |
66,751
+12,451
| +23% | +$143K | ﹤0.01% | 1181 |
|
|
2023
Q1 | $419K | Hold |
54,300
| – | – | ﹤0.01% | 1299 |
|
|
2022
Q4 | $331K | Hold |
54,300
| – | – | ﹤0.01% | 1343 |
|
|
2022
Q3 | $326K | Hold |
54,300
| – | – | ﹤0.01% | 1362 |
|
|
2022
Q2 | $321K | Buy |
+54,300
| New | +$321K | ﹤0.01% | 1348 |
|